Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Aug;108(Suppl 4):751–762. doi: 10.1289/ehp.00108s4751

Interstitial fibrosis and growth factors.

J A Lasky 1, A R Brody 1
PMCID: PMC1637668  PMID: 10931794

Abstract

Interstitial pulmonary fibrosis (IPF) is scarring of the lung caused by a variety of inhaled agents including mineral particles, organic dusts, and oxidant gases. The disease afflicts millions of individuals worldwide, and there are no effective therapeutic approaches. A major reason for this lack of useful treatments is that few of the molecular mechanisms of disease have been defined sufficiently to design appropriate targets for therapy. Our laboratory has focused on the molecular mechanisms through which three selected peptide growth factors could play a role in the development of IPF. Hundreds of growth factors and cytokines could be involved in the complex disease process. We are studying platelet-derived growth factor because it is the most potent mesenchymal cell mitogen yet described, transforming growth factor beta because it is a powerful inducer of extracellular matrix (scar tissue) components by mesenchymal cells, and tumor necrosis factor alpha because it is a pleiotropic cytokine that we and others have shown is essential for the development of IPF in animal models. This review describes some of the evidence from studies in humans, in animal models, and in vitro, that supports the growth factor hypothesis. The use of modern molecular and transgenic technologies could elucidate those targets that will allow effective therapeutic approaches.

Full text

PDF
751

Images in this article

756Figure 1
on p.756
759Figure 2
on p.759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abboud H. E., Poptic E., DiCorleto P. Production of platelet-derived growth factorlike protein by rat mesangial cells in culture. J Clin Invest. 1987 Sep;80(3):675–683. doi: 10.1172/JCI113121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adler K. B., Low R. B., Leslie K. O., Mitchell J., Evans J. N. Contractile cells in normal and fibrotic lung. Lab Invest. 1989 Apr;60(4):473–485. [PubMed] [Google Scholar]
  3. Agarwal A. R., Goldstein R. H., Lucey E., Ngo H. Q., Smith B. D. Cell-specific expression of the alpha 1 (I) collagen promoter-CAT transgene in skin and lung: a response to TGF-beta subcutaneous injection and bleomycin endotracheal instillation. J Cell Biochem. 1996 Nov 1;63(2):135–148. doi: 10.1002/(SICI)1097-4644(19961101)63:2%3C135::AID-JCB2%3E3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  4. Antoniades H. N., Bravo M. A., Avila R. E., Galanopoulos T., Neville-Golden J., Maxwell M., Selman M. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest. 1990 Oct;86(4):1055–1064. doi: 10.1172/JCI114808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Antoniades H. N. Linking cellular injury to gene expression and human proliferative disorders: examples with the PDGF genes. Mol Carcinog. 1992;6(3):175–181. doi: 10.1002/mc.2940060302. [DOI] [PubMed] [Google Scholar]
  6. Asakura S., Colby T. V., Limper A. H. Tissue localization of transforming growth factor-beta1 in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med. 1996 Nov;154(5):1525–1530. doi: 10.1164/ajrccm.154.5.8912775. [DOI] [PubMed] [Google Scholar]
  7. Awad M. R., El-Gamel A., Hasleton P., Turner D. M., Sinnott P. J., Hutchinson I. V. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998 Oct 27;66(8):1014–1020. doi: 10.1097/00007890-199810270-00009. [DOI] [PubMed] [Google Scholar]
  8. Banai S., Wolf Y., Golomb G., Pearle A., Waltenberger J., Fishbein I., Schneider A., Gazit A., Perez L., Huber R. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation. 1998 May 19;97(19):1960–1969. doi: 10.1161/01.cir.97.19.1960. [DOI] [PubMed] [Google Scholar]
  9. Barth J., Kreipe H., Radzun H. J., Heidorn K., Petermann W., Bewig B., Parwaresch M. R. Increased expression of growth factor genes for macrophages and fibroblasts in bronchoalveolar lavage cells of a patient with pulmonary histiocytosis X. Thorax. 1991 Nov;46(11):835–838. doi: 10.1136/thx.46.11.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Battegay E. J., Raines E. W., Colbert T., Ross R. TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol. 1995 Jun 1;154(11):6040–6047. [PubMed] [Google Scholar]
  11. Battegay E. J., Raines E. W., Seifert R. A., Bowen-Pope D. F., Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990 Nov 2;63(3):515–524. doi: 10.1016/0092-8674(90)90448-n. [DOI] [PubMed] [Google Scholar]
  12. Baumgartner K. B., Samet J. M., Stidley C. A., Colby T. V., Waldron J. A. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997 Jan;155(1):242–248. doi: 10.1164/ajrccm.155.1.9001319. [DOI] [PubMed] [Google Scholar]
  13. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996 Jun 27;334(26):1717–1725. doi: 10.1056/NEJM199606273342607. [DOI] [PubMed] [Google Scholar]
  14. Beutler B., van Huffel C. Unraveling function in the TNF ligand and receptor families. Science. 1994 Apr 29;264(5159):667–668. doi: 10.1126/science.8171316. [DOI] [PubMed] [Google Scholar]
  15. Bienkowski R. S., Gotkin M. G. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med. 1995 Jun;209(2):118–140. doi: 10.3181/00379727-209-43886a. [DOI] [PubMed] [Google Scholar]
  16. Bonner J. C., Brody A. R. Cytokine-binding proteins in the lung. Am J Physiol. 1995 Jun;268(6 Pt 1):L869–L878. doi: 10.1152/ajplung.1995.268.6.L869. [DOI] [PubMed] [Google Scholar]
  17. Bonner J. C., Goodell A. L., Coin P. G., Brody A. R. Chrysotile asbestos upregulates gene expression and production of alpha-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts. J Clin Invest. 1993 Jul;92(1):425–430. doi: 10.1172/JCI116584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bonner J. C., Goodell A. L., Lasky J. A., Hoffman M. R. Reversible binding of platelet-derived growth factor-AA, -AB, and -BB isoforms to a similar site on the "slow" and "fast" conformations of alpha 2-macroglobulin. J Biol Chem. 1992 Jun 25;267(18):12837–12844. [PubMed] [Google Scholar]
  19. Bonner J. C., Osornio-Vargas A. R., Badgett A., Brody A. R. Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages. Am J Respir Cell Mol Biol. 1991 Dec;5(6):539–547. doi: 10.1165/ajrcmb/5.6.539. [DOI] [PubMed] [Google Scholar]
  20. Boström H., Willetts K., Pekny M., Levéen P., Lindahl P., Hedstrand H., Pekna M., Hellström M., Gebre-Medhin S., Schalling M. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996 Jun 14;85(6):863–873. doi: 10.1016/s0092-8674(00)81270-2. [DOI] [PubMed] [Google Scholar]
  21. Brass D. M., Hoyle G. W., Poovey H. G., Liu J. Y., Brody A. R. Reduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am J Pathol. 1999 Mar;154(3):853–862. doi: 10.1016/s0002-9440(10)65332-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Brenner D. A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989 Feb 16;337(6208):661–663. doi: 10.1038/337661a0. [DOI] [PubMed] [Google Scholar]
  23. Brody A. R., Bonner J. C., Overby L. H., Badgett A., Kalter V., Kumar R. K., Bennett R. A. Interstitial pulmonary macrophages produce platelet-derived growth factor that stimulates rat lung fibroblast proliferation in vitro. J Leukoc Biol. 1992 Jun;51(6):640–648. doi: 10.1002/jlb.51.6.640. [DOI] [PubMed] [Google Scholar]
  24. Broekelmann T. J., Limper A. H., Colby T. V., McDonald J. A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6642–6646. doi: 10.1073/pnas.88.15.6642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Burger A., Löffler H., Bamberg M., Rodemann H. P. Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol. 1998 Apr;73(4):401–408. doi: 10.1080/095530098142239. [DOI] [PubMed] [Google Scholar]
  26. Böttinger E. P., Jakubczak J. L., Haines D. C., Bagnall K., Wakefield L. M. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res. 1997 Dec 15;57(24):5564–5570. [PubMed] [Google Scholar]
  27. Cain W. C., Stuart R. W., Lefkowitz D. L., Starnes J. D., Margolin S., Lefkowitz S. S. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone. Int J Immunopharmacol. 1998 Dec;20(12):685–695. doi: 10.1016/s0192-0561(98)00042-3. [DOI] [PubMed] [Google Scholar]
  28. Carrington C. B., Gaensler E. A., Coutu R. E., FitzGerald M. X., Gupta R. G. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med. 1978 Apr 13;298(15):801–809. doi: 10.1056/NEJM197804132981501. [DOI] [PubMed] [Google Scholar]
  29. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Chang L. Y., Overby L. H., Brody A. R., Crapo J. D. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol. 1988 Apr;131(1):156–170. [PMC free article] [PubMed] [Google Scholar]
  31. Chen B., Polunovsky V., White J., Blazar B., Nakhleh R., Jessurun J., Peterson M., Bitterman P. Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype. J Clin Invest. 1992 Nov;90(5):1778–1785. doi: 10.1172/JCI116052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Coker R. K., Laurent G. J., Shahzeidi S., Lympany P. A., du Bois R. M., Jeffery P. K., McAnulty R. J. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 1997 Mar;150(3):981–991. [PMC free article] [PubMed] [Google Scholar]
  33. Coultas D. B., Zumwalt R. E., Black W. C., Sobonya R. E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994 Oct;150(4):967–972. doi: 10.1164/ajrccm.150.4.7921471. [DOI] [PubMed] [Google Scholar]
  34. Crawford S. E., Stellmach V., Murphy-Ullrich J. E., Ribeiro S. M., Lawler J., Hynes R. O., Boivin G. P., Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998 Jun 26;93(7):1159–1170. doi: 10.1016/s0092-8674(00)81460-9. [DOI] [PubMed] [Google Scholar]
  35. Crosby J. R., Tappan K. A., Seifert R. A., Bowen-Pope D. F. Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development. Am J Pathol. 1999 May;154(5):1315–1321. doi: 10.1016/s0002-9440(10)65384-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Dai J., Gilks B., Price K., Churg A. Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall. Am J Respir Crit Care Med. 1998 Dec;158(6):1907–1913. doi: 10.1164/ajrccm.158.6.9805010. [DOI] [PubMed] [Google Scholar]
  37. Davis G. S., Pfeiffer L. M., Hemenway D. R. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol. 1998;17(2):99–114. [PubMed] [Google Scholar]
  38. Deguchi Y., Kishimoto S. Enhancement of c-sis protooncogene transcription in bronchoalveolar mononuclear cells from patients with autoimmune diseases with lung involvement. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1018–1023. doi: 10.1016/0006-291x(89)91771-3. [DOI] [PubMed] [Google Scholar]
  39. Diaz A., Munoz E., Johnston R., Korn J. H., Jimenez S. A. Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem. 1993 May 15;268(14):10364–10371. [PubMed] [Google Scholar]
  40. Doré J. J., Jr, Edens M., Garamszegi N., Leof E. B. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells. J Biol Chem. 1998 Nov 27;273(48):31770–31777. doi: 10.1074/jbc.273.48.31770. [DOI] [PubMed] [Google Scholar]
  41. Douglas W. W., Ryu J. H., Swensen S. J., Offord K. P., Schroeder D. R., Caron G. M., DeRemee R. A. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. Am J Respir Crit Care Med. 1998 Jul;158(1):220–225. doi: 10.1164/ajrccm.158.1.9709089. [DOI] [PubMed] [Google Scholar]
  42. Driscoll K. E., Hassenbein D. G., Carter J. M., Kunkel S. L., Quinlan T. R., Mossman B. T. TNF alpha and increased chemokine expression in rat lung after particle exposure. Toxicol Lett. 1995 Dec;82-83:483–489. doi: 10.1016/0378-4274(95)03578-8. [DOI] [PubMed] [Google Scholar]
  43. Dubaybo B. A. Role of tumor necrosis factor-alpha in regulating fibrotic lung repair. Res Commun Mol Pathol Pharmacol. 1998 Jul;101(1):69–83. [PubMed] [Google Scholar]
  44. Ebner R., Chen R. H., Shum L., Lawler S., Zioncheck T. F., Lee A., Lopez A. R., Derynck R. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science. 1993 May 28;260(5112):1344–1348. doi: 10.1126/science.8388127. [DOI] [PubMed] [Google Scholar]
  45. Eickelberg O., Köhler E., Reichenberger F., Bertschin S., Woodtli T., Erne P., Perruchoud A. P., Roth M. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol. 1999 May;276(5 Pt 1):L814–L824. doi: 10.1152/ajplung.1999.276.5.L814. [DOI] [PubMed] [Google Scholar]
  46. Elias J. A., Freundlich B., Adams S., Rosenbloom J. Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-gamma. Ann N Y Acad Sci. 1990;580:233–244. doi: 10.1111/j.1749-6632.1990.tb17932.x. [DOI] [PubMed] [Google Scholar]
  47. Entzian P., Schlaak M., Seitzer U., Bufe A., Acil Y., Zabel P. Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung. 1997;175(1):41–51. doi: 10.1007/pl00007555. [DOI] [PubMed] [Google Scholar]
  48. Fabisiak J. P., Evans J. N., Absher M., Gannon D., Kelley J. Expression of platelet-derived growth factor A-chain (PDGF-A) mRNA in lung tissue and cells. Complex regulation during remodeling. Chest. 1991 Mar;99(3 Suppl):52S–54S. doi: 10.1378/chest.99.3_supplement.52s. [DOI] [PubMed] [Google Scholar]
  49. Fabisiak J. P., Evans J. N., Kelley J. Increased expression of PDGF-B (c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during chronic hyperoxia. Am J Respir Cell Mol Biol. 1989 Sep;1(3):181–189. doi: 10.1165/ajrcmb/1.3.181. [DOI] [PubMed] [Google Scholar]
  50. Facon T., Goudemand J., Caron C., Zandecki M., Estienne M. H., Fenaux P., Cosson A. Simultaneous occurrence of grey platelet syndrome and idiopathic pulmonary fibrosis: a role for abnormal megakaryocytes in the pathogenesis of pulmonary fibrosis? Br J Haematol. 1990 Apr;74(4):542–543. doi: 10.1111/j.1365-2141.1990.tb06350.x. [DOI] [PubMed] [Google Scholar]
  51. Fine A., Goldstein R. H. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem. 1987 Mar 15;262(8):3897–3902. [PubMed] [Google Scholar]
  52. Franko A. J., Sharplin J., Ghahary A., Barcellos-Hoff M. H. Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation. Radiat Res. 1997 Feb;147(2):245–256. [PubMed] [Google Scholar]
  53. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G. R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996 Sep;107(3):404–411. doi: 10.1111/1523-1747.ep12363389. [DOI] [PubMed] [Google Scholar]
  54. Galbraith G. M., Pandey J. P., Schmidt M. G., Arnaud P., Goust J. M. Tumor necrosis factor alpha gene expression in human monocytic THP-1 cells exposed to beryllium. Arch Environ Health. 1996 Jan-Feb;51(1):29–33. doi: 10.1080/00039896.1996.9935990. [DOI] [PubMed] [Google Scholar]
  55. Gauldie J., Sime P. J., Xing Z., Marr B., Tremblay G. M. Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr Top Pathol. 1999;93:35–45. doi: 10.1007/978-3-642-58456-5_5. [DOI] [PubMed] [Google Scholar]
  56. Geismar L. S., Hennessey S., Reiser K. M., Last J. A. D-penicillamine prevents collagen accumulation in lungs of rats given bleomycin. Chest. 1986 Mar;89(3 Suppl):153S–154S. doi: 10.1378/chest.89.3_supplement.153s. [DOI] [PubMed] [Google Scholar]
  57. Gharaee-Kermani M., McGarry B., Lukacs N., Huffnagle G., Egan R. W., Phan S. H. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol. 1998 Nov;64(5):657–666. doi: 10.1002/jlb.64.5.657. [DOI] [PubMed] [Google Scholar]
  58. Giri S. N., Hyde D. M., Braun R. K., Gaarde W., Harper J. R., Pierschbacher M. D. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol. 1997 Dec 1;54(11):1205–1216. doi: 10.1016/s0006-2952(97)00343-2. [DOI] [PubMed] [Google Scholar]
  59. Giri S. N., Hyde D. M., Hollinger M. A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax. 1993 Oct;48(10):959–966. doi: 10.1136/thx.48.10.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Goldstein R. H., Fine A. Fibrotic reactions in the lung: the activation of the lung fibroblast. Exp Lung Res. 1986;11(4):245–261. doi: 10.3109/01902148609062828. [DOI] [PubMed] [Google Scholar]
  61. Gossart S., Cambon C., Orfila C., Séguélas M. H., Lepert J. C., Rami J., Carré P., Pipy B. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica. J Immunol. 1996 Feb 15;156(4):1540–1548. [PubMed] [Google Scholar]
  62. Grotendorst G. R. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1997 Sep;8(3):171–179. doi: 10.1016/s1359-6101(97)00010-5. [DOI] [PubMed] [Google Scholar]
  63. Gurujeyalakshmi G., Hollinger M. A., Giri S. N. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol. 1999 Feb;276(2 Pt 1):L311–L318. doi: 10.1152/ajplung.1999.276.2.L311. [DOI] [PubMed] [Google Scholar]
  64. Hagimoto N., Kuwano K., Miyazaki H., Kunitake R., Fujita M., Kawasaki M., Kaneko Y., Hara N. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol. 1997 Sep;17(3):272–278. doi: 10.1165/ajrcmb.17.3.2893. [DOI] [PubMed] [Google Scholar]
  65. Hart C. E., Forstrom J. W., Kelly J. D., Seifert R. A., Smith R. A., Ross R., Murray M. J., Bowen-Pope D. F. Two classes of PDGF receptor recognize different isoforms of PDGF. Science. 1988 Jun 10;240(4858):1529–1531. doi: 10.1126/science.2836952. [DOI] [PubMed] [Google Scholar]
  66. Heine U. I., Munoz E. F., Flanders K. C., Roberts A. B., Sporn M. B. Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. Development. 1990 May;109(1):29–36. doi: 10.1242/dev.109.1.29. [DOI] [PubMed] [Google Scholar]
  67. Heldin C. H., Johnsson A., Wennergren S., Wernstedt C., Betsholtz C., Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature. 1986 Feb 6;319(6053):511–514. doi: 10.1038/319511a0. [DOI] [PubMed] [Google Scholar]
  68. Heldin C. H., Westermark B. Signal transduction by the receptors for platelet-derived growth factor. J Cell Sci. 1990 Jun;96(Pt 2):193–196. doi: 10.1242/jcs.96.2.193. [DOI] [PubMed] [Google Scholar]
  69. Hertz M. I., Henke C. A., Nakhleh R. E., Harmon K. R., Marinelli W. A., Fox J. M., Kubo S. H., Shumway S. J., Bolman R. M., 3rd, Bitterman P. B. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10385–10389. doi: 10.1073/pnas.89.21.10385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Hiwatari N., Shimura S., Yamauchi K., Nara M., Hida W., Shirato K. Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients. Tohoku J Exp Med. 1997 Feb;181(2):285–295. doi: 10.1620/tjem.181.285. [DOI] [PubMed] [Google Scholar]
  71. Homma S., Nagaoka I., Abe H., Takahashi K., Seyama K., Nukiwa T., Kira S. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2084–2089. doi: 10.1164/ajrccm.152.6.8520779. [DOI] [PubMed] [Google Scholar]
  72. Hoyle G. W., Li J., Finkelstein J. B., Eisenberg T., Liu J. Y., Lasky J. A., Athas G., Morris G. F., Brody A. R. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol. 1999 Jun;154(6):1763–1775. doi: 10.1016/S0002-9440(10)65432-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Hoyt D. G., Lazo J. S. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 1988 Aug;246(2):765–771. [PubMed] [Google Scholar]
  74. Huang S. S., Liu Q., Johnson F. E., Konish Y., Huang J. S. Transforming growth factor beta peptide antagonists and their conversion to partial agonists. J Biol Chem. 1997 Oct 24;272(43):27155–27159. doi: 10.1074/jbc.272.43.27155. [DOI] [PubMed] [Google Scholar]
  75. Hubbard R., Lewis S., Richards K., Johnston I., Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet. 1996 Feb 3;347(8997):284–289. doi: 10.1016/s0140-6736(96)90465-1. [DOI] [PubMed] [Google Scholar]
  76. Ishikawa O., LeRoy E. C., Trojanowska M. Mitogenic effect of transforming growth factor beta 1 on human fibroblasts involves the induction of platelet-derived growth factor alpha receptors. J Cell Physiol. 1990 Oct;145(1):181–186. doi: 10.1002/jcp.1041450124. [DOI] [PubMed] [Google Scholar]
  77. Iyer S. N., Gurujeyalakshmi G., Giri S. N. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther. 1999 Apr;289(1):211–218. [PubMed] [Google Scholar]
  78. Jagirdar J., Begin R., Dufresne A., Goswami S., Lee T. C., Rom W. N. Transforming growth factor-beta (TGF-beta) in silicosis. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1076–1081. doi: 10.1164/ajrccm.154.4.8887610. [DOI] [PubMed] [Google Scholar]
  79. Jagirdar J., Lee T. C., Reibman J., Gold L. I., Aston C., Bégin R., Rom W. N. Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Perspect. 1997 Sep;105 (Suppl 5):1197–1203. doi: 10.1289/ehp.97105s51197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Johnson M. A., Kwan S., Snell N. J., Nunn A. J., Darbyshire J. H., Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989 Apr;44(4):280–288. doi: 10.1136/thx.44.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Johnston C. J., Piedboeuf B., Rubin P., Williams J. P., Baggs R., Finkelstein J. N. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res. 1996 Jun;145(6):762–767. [PubMed] [Google Scholar]
  82. Kaartinen V., Voncken J. W., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet. 1995 Dec;11(4):415–421. doi: 10.1038/ng1295-415. [DOI] [PubMed] [Google Scholar]
  83. Kallio E., Koskinen P., Buchdunger E., Lemström K. Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor. Transplant Proc. 1999 Feb-Mar;31(1-2):187–187. doi: 10.1016/s0041-1345(98)01496-1. [DOI] [PubMed] [Google Scholar]
  84. Kalter V. G., Brody A. R. Receptors for transforming growth factor-beta (TGF-beta) on rat lung fibroblasts have higher affinity for TGF-beta 1 than for TGF-beta 2. Am J Respir Cell Mol Biol. 1991 May;4(5):397–407. doi: 10.1165/ajrcmb/4.5.397. [DOI] [PubMed] [Google Scholar]
  85. Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990 Mar;141(3):765–788. doi: 10.1164/ajrccm/141.3.765. [DOI] [PubMed] [Google Scholar]
  86. Khalil N., Corne S., Whitman C., Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol. 1996 Aug;15(2):252–259. doi: 10.1165/ajrcmb.15.2.8703482. [DOI] [PubMed] [Google Scholar]
  87. Khalil N., O'Connor R. N., Flanders K. C., Shing W., Whitman C. I. Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats. Am J Physiol. 1994 Nov;267(5 Pt 1):L498–L507. doi: 10.1152/ajplung.1994.267.5.L498. [DOI] [PubMed] [Google Scholar]
  88. Kienast K., Bay M., Drumm K., Smolarski R., Ferlinz R. Modulation of TNF-alpha secretions by alveolar macrophages and blood monocytes after soot-particle or asbestos fibre exposure. Eur J Med Res. 1996 Jun 25;1(9):425–428. [PubMed] [Google Scholar]
  89. Kolls J. K., Lei D., Nelson S., Summer W. R., Greenberg S., Beutler B. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J Infect Dis. 1995 Mar;171(3):570–575. doi: 10.1093/infdis/171.3.570. [DOI] [PubMed] [Google Scholar]
  90. Kolls J. K., Lei D., Vazquez C., Odom G., Summer W. R., Nelson S., Shellito J. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am J Respir Cell Mol Biol. 1997 Feb;16(2):112–118. doi: 10.1165/ajrcmb.16.2.9032117. [DOI] [PubMed] [Google Scholar]
  91. Krupsky M., Fine A., Kuang P. P., Berk J. L., Goldstein R. H. Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblasts. Connect Tissue Res. 1996;34(1):53–62. doi: 10.3109/03008209609028893. [DOI] [PubMed] [Google Scholar]
  92. Larsson O., Latham C., Zickert P., Zetterberg A. Cell cycle regulation of human diploid fibroblasts: possible mechanisms of platelet-derived growth factor. J Cell Physiol. 1989 Jun;139(3):477–483. doi: 10.1002/jcp.1041390305. [DOI] [PubMed] [Google Scholar]
  93. Lasky J. A., Bonner J. C., Tonthat B., Brody A. R. Chrysotile asbestos induces PDGF-A chain-dependent proliferation in human and rat lung fibroblasts in vitro. Chest. 1996 Mar;109(3 Suppl):26S–28S. doi: 10.1378/chest.109.3_supplement.02s6-a. [DOI] [PubMed] [Google Scholar]
  94. Lasky J. A., Coin P. G., Lindroos P. M., Ostrowski L. E., Brody A. R., Bonner J. C. Chrysotile asbestos stimulates platelet-derived growth factor-AA production by rat lung fibroblasts in vitro: evidence for an autocrine loop. Am J Respir Cell Mol Biol. 1995 Feb;12(2):162–170. doi: 10.1165/ajrcmb.12.2.7865215. [DOI] [PubMed] [Google Scholar]
  95. Lasky J. A., Tonthat B., Liu J. Y., Friedman M., Brody A. R. Upregulation of the PDGF-alpha receptor precedes asbestos-induced lung fibrosis in rats. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1652–1657. doi: 10.1164/ajrccm.157.5.9704116. [DOI] [PubMed] [Google Scholar]
  96. Lee T. C., Gold L. I., Reibman J., Aston C., Bégin R., Rom W. N., Jagirdar J. Immunohistochemical localization of transforming growth factor-beta and insulin-like growth factor-I in asbestosis in the sheep model. Int Arch Occup Environ Health. 1997;69(3):157–164. doi: 10.1007/s004200050132. [DOI] [PubMed] [Google Scholar]
  97. Leof E. B., Proper J. A., Goustin A. S., Shipley G. D., DiCorleto P. E., Moses H. L. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2453–2457. doi: 10.1073/pnas.83.8.2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994 Aug 15;8(16):1875–1887. doi: 10.1101/gad.8.16.1875. [DOI] [PubMed] [Google Scholar]
  99. Li J., He B., Weng B. [The therapeutic effect of TGF-beta monoclonal antibody to bleomycin-induced pulmonary fibrosis in rats]. Zhonghua Jie He He Hu Xi Za Zhi. 1997 Dec;20(6):347–349. [PubMed] [Google Scholar]
  100. Limper A. H., Broekelmann T. J., Colby T. V., Malizia G., McDonald J. A. Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. Chest. 1991 Mar;99(3 Suppl):55S–56S. doi: 10.1378/chest.99.3_supplement.55s. [DOI] [PubMed] [Google Scholar]
  101. Limper A. H., Colby T. V., Sanders M. S., Asakura S., Roche P. C., DeRemee R. A. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med. 1994 Jan;149(1):197–204. doi: 10.1164/ajrccm.149.1.8111583. [DOI] [PubMed] [Google Scholar]
  102. Lin J., Liliensiek B., Kanitz M., Schimanski U., Böhrer H., Waldherr R., Martin E., Kauffmann G., Ziegler R., Nawroth P. P. Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc Res. 1998 Jun;38(3):802–813. doi: 10.1016/s0008-6363(98)00055-8. [DOI] [PubMed] [Google Scholar]
  103. Lindahl P., Karlsson L., Hellström M., Gebre-Medhin S., Willetts K., Heath J. K., Betsholtz C. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development. 1997 Oct;124(20):3943–3953. doi: 10.1242/dev.124.20.3943. [DOI] [PubMed] [Google Scholar]
  104. Lindroos P. M., Coin P. G., Badgett A., Morgan D. L., Bonner J. C. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism. Am J Respir Cell Mol Biol. 1997 Mar;16(3):283–292. doi: 10.1165/ajrcmb.16.3.9070613. [DOI] [PubMed] [Google Scholar]
  105. Lindroos P. M., Coin P. G., Osornio-Vargas A. R., Bonner J. C. Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts. Am J Respir Cell Mol Biol. 1995 Oct;13(4):455–465. doi: 10.1165/ajrcmb.13.4.7546776. [DOI] [PubMed] [Google Scholar]
  106. Liu J. Y., Brass D. M., Hoyle G. W., Brody A. R. TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol. 1998 Dec;153(6):1839–1847. doi: 10.1016/s0002-9440(10)65698-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Liu J. Y., Morris G. F., Lei W. H., Hart C. E., Lasky J. A., Brody A. R. Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats. Am J Respir Cell Mol Biol. 1997 Aug;17(2):129–140. doi: 10.1165/ajrcmb.17.2.2956. [DOI] [PubMed] [Google Scholar]
  108. Lou J., Donati Y. R., Juillard P., Giroud C., Vesin C., Mili N., Grau G. E. Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol. 1997 Nov;151(5):1397–1405. [PMC free article] [PubMed] [Google Scholar]
  109. Ludwicka A., Ohba T., Trojanowska M., Yamakage A., Strange C., Smith E. A., Leroy E. C., Sutherland S., Silver R. M. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol. 1995 Oct;22(10):1876–1883. [PubMed] [Google Scholar]
  110. Majack R. A., Majesky M. W., Goodman L. V. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J Cell Biol. 1990 Jul;111(1):239–247. doi: 10.1083/jcb.111.1.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Majesky M. W., Benditt E. P., Schwartz S. M. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1524–1528. doi: 10.1073/pnas.85.5.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Mariani T. J., Roby J. D., Mecham R. P., Parks W. C., Crouch E., Pierce R. A. Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-beta as a mediator of fibrosis. Am J Pathol. 1996 Jan;148(1):151–164. [PMC free article] [PubMed] [Google Scholar]
  113. Martinet Y., Rom W. N., Grotendorst G. R., Martin G. R., Crystal R. G. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med. 1987 Jul 23;317(4):202–209. doi: 10.1056/NEJM198707233170404. [DOI] [PubMed] [Google Scholar]
  114. Martinez J. A., King T. E., Jr, Brown K., Jennings C. A., Borish L., Mortenson R. L., Khan T. Z., Bost T. W., Riches D. W. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol. 1997 Sep;273(3 Pt 1):L676–L683. doi: 10.1152/ajplung.1997.273.3.L676. [DOI] [PubMed] [Google Scholar]
  115. Matrat M., Lardot C., Huaux F., Broeckaert F., Lison D. Role of urokinase in the activation of macrophage-associated TGF-beta in silica-induced lung fibrosis. J Toxicol Environ Health A. 1998 Nov 13;55(5):359–371. doi: 10.1080/009841098158403. [DOI] [PubMed] [Google Scholar]
  116. McAnulty R. J., Campa J. S., Cambrey A. D., Laurent G. J. The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta. 1991 Jan 31;1091(2):231–235. doi: 10.1016/0167-4889(91)90066-7. [DOI] [PubMed] [Google Scholar]
  117. Miyazaki Y., Araki K., Vesin C., Garcia I., Kapanci Y., Whitsett J. A., Piguet P. F., Vassalli P. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest. 1995 Jul;96(1):250–259. doi: 10.1172/JCI118029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Moolman J. A., Bardin P. G., Rossouw D. J., Joubert J. R. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax. 1991 Aug;46(8):592–595. doi: 10.1136/thx.46.8.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Mori K., Hatamochi A., Ueki H., Olsen A., Jimenez S. A. The transcription of human alpha 1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-alpha through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear-factorbinding sites. Biochem J. 1996 Nov 1;319(Pt 3):811–816. doi: 10.1042/bj3190811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Moss M. L., Jin S. L., Milla M. E., Bickett D. M., Burkhart W., Carter H. L., Chen W. J., Clay W. C., Didsbury J. R., Hassler D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997 Feb 20;385(6618):733–736. doi: 10.1038/385733a0. [DOI] [PubMed] [Google Scholar]
  121. Munger J. S., Huang X., Kawakatsu H., Griffiths M. J., Dalton S. L., Wu J., Pittet J. F., Kaminski N., Garat C., Matthay M. A. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999 Feb 5;96(3):319–328. doi: 10.1016/s0092-8674(00)80545-0. [DOI] [PubMed] [Google Scholar]
  122. Nagaoka I., Trapnell B. C., Crystal R. G. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest. 1990 Jun;85(6):2023–2027. doi: 10.1172/JCI114669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Nakagawa H., Kitagawa H., Aikawa Y. Tumor necrosis factor stimulates gelatinase and collagenase production by granulation tissue in culture. Biochem Biophys Res Commun. 1987 Feb 13;142(3):791–797. doi: 10.1016/0006-291x(87)91483-5. [DOI] [PubMed] [Google Scholar]
  124. Oefner C., D'Arcy A., Winkler F. K., Eggimann B., Hosang M. Crystal structure of human platelet-derived growth factor BB. EMBO J. 1992 Nov;11(11):3921–3926. doi: 10.1002/j.1460-2075.1992.tb05485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Ohtsuka Y., Munakata M., Ukita H., Takahashi T., Satoh A., Homma Y., Kawakami Y. Increased susceptibility to silicosis and TNF-alpha production in C57BL/6J mice. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2144–2149. doi: 10.1164/ajrccm.152.6.8520788. [DOI] [PubMed] [Google Scholar]
  126. Okano A., Sato A., Chida K., Hayakawa H., Iwata M., Yasuda K., Shichi I., Suda T., Maeda T. [Pulmonary interstitial pneumonia in association with Hermansky-Pudlak syndrome]. Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Dec;29(12):1596–1602. [PubMed] [Google Scholar]
  127. Okazaki H., Majesky M. W., Harker L. A., Schwartz S. M. Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ Res. 1992 Dec;71(6):1285–1293. doi: 10.1161/01.res.71.6.1285. [DOI] [PubMed] [Google Scholar]
  128. Ortiz L. A., Lasky J., Hamilton R. F., Jr, Holian A., Hoyle G. W., Banks W., Peschon J. J., Brody A. R., Lungarella G., Friedman M. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res. 1998 Nov-Dec;24(6):721–743. doi: 10.3109/01902149809099592. [DOI] [PubMed] [Google Scholar]
  129. Ortiz L. A., Lasky J., Lungarella G., Cavarra E., Martorana P., Banks W. A., Peschon J. J., Schmidts H. L., Brody A. R., Friedman M. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol. 1999 Apr;20(4):825–833. doi: 10.1165/ajrcmb.20.4.3193. [DOI] [PubMed] [Google Scholar]
  130. Osornio-Vargas A. R., Hernández-Rodríguez N. A., Yáez-Buruel A. G., Ussler W., Overby L. H., Brody A. R. Lung cell toxicity experimentally induced by a mixed dust from Mexicali, Baja California, Mexico. Environ Res. 1991 Oct;56(1):31–47. doi: 10.1016/s0013-9351(05)80107-0. [DOI] [PubMed] [Google Scholar]
  131. Paulsson Y., Austgulen R., Hofsli E., Heldin C. H., Westermark B., Nissen-Meyer J. Tumor necrosis factor-induced expression of platelet-derived growth factor A-chain messenger RNA in fibroblasts. Exp Cell Res. 1989 Feb;180(2):490–496. doi: 10.1016/0014-4827(89)90075-x. [DOI] [PubMed] [Google Scholar]
  132. Perdue T. D., Brody A. R. Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J Histochem Cytochem. 1994 Aug;42(8):1061–1070. doi: 10.1177/42.8.8027525. [DOI] [PubMed] [Google Scholar]
  133. Phan S. H., Kunkel S. L. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res. 1992 Jan-Mar;18(1):29–43. doi: 10.3109/01902149209020649. [DOI] [PubMed] [Google Scholar]
  134. Piguet P. F., Collart M. A., Grau G. E., Kapanci Y., Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med. 1989 Sep 1;170(3):655–663. doi: 10.1084/jem.170.3.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Piguet P. F., Collart M. A., Grau G. E., Sappino A. P., Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 1990 Mar 15;344(6263):245–247. doi: 10.1038/344245a0. [DOI] [PubMed] [Google Scholar]
  136. Piguet P. F., Kaufman S., Barazzone C., Muller M., Ryffel B., Eugster H. P. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis. Int J Exp Pathol. 1997 Feb;78(1):43–48. doi: 10.1046/j.1365-2613.1997.d01-240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Piguet P. F., Ribaux C., Karpuz V., Grau G. E., Kapanci Y. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol. 1993 Sep;143(3):651–655. [PMC free article] [PubMed] [Google Scholar]
  138. Piguet P. F., Van G. Y., Guo J. Heparin attenuates bleomycin but not silica-induced pulmonary fibrosis in mice: possible relationship with involvement of myofibroblasts in bleomycin, and fibroblasts in silica-induced fibrosis. Int J Exp Pathol. 1996 Aug;77(4):155–161. doi: 10.1046/j.1365-2613.1996.d01-214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Piguet P. F., Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J. 1994 Mar;7(3):515–518. doi: 10.1183/09031936.94.07030515. [DOI] [PubMed] [Google Scholar]
  140. Raghu G., Depaso W. J., Cain K., Hammar S. P., Wetzel C. E., Dreis D. F., Hutchinson J., Pardee N. E., Winterbauer R. H. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis. 1991 Aug;144(2):291–296. doi: 10.1164/ajrccm/144.2.291. [DOI] [PubMed] [Google Scholar]
  141. Raghu G., Johnson W. C., Lockhart D., Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1061–1069. doi: 10.1164/ajrccm.159.4.9805017. [DOI] [PubMed] [Google Scholar]
  142. Raines E. W., Dower S. K., Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989 Jan 20;243(4889):393–396. doi: 10.1126/science.2783498. [DOI] [PubMed] [Google Scholar]
  143. Reinhart P. G., Gairola C. G. Amiodarone-induced pulmonary toxicity in Fischer rats: release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages. J Toxicol Environ Health. 1997 Nov;52(4):353–365. doi: 10.1080/00984109708984070. [DOI] [PubMed] [Google Scholar]
  144. Rosenfeld M. E., Bowen-Pope D. F., Ross R. Platelet-derived growth factor: morphologic and biochemical studies of binding, internalization, and degradation. J Cell Physiol. 1984 Nov;121(2):263–274. doi: 10.1002/jcp.1041210202. [DOI] [PubMed] [Google Scholar]
  145. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. doi: 10.1073/pnas.71.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Salez F., Gosset P., Copin M. C., Lamblin Degros C., Tonnel A. B., Wallaert B. Transforming growth factor-beta1 in sarcoidosis. Eur Respir J. 1998 Oct;12(4):913–919. doi: 10.1183/09031936.98.12040913. [DOI] [PubMed] [Google Scholar]
  147. Saunders W. B. Nautilus growth and longevity: evidence from marked and recaptured animals. Science. 1984 Jun 1;224(4652):990–992. doi: 10.1126/science.224.4652.990. [DOI] [PubMed] [Google Scholar]
  148. Schwarz M. I. Idiopathic pulmonary fibrosis. West J Med. 1988 Aug;149(2):199–203. [PMC free article] [PubMed] [Google Scholar]
  149. Schöllmann C., Grugel R., Tatje D., Hoppe J., Folkman J., Marmé D., Weich H. A. Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells. J Biol Chem. 1992 Sep 5;267(25):18032–18039. [PubMed] [Google Scholar]
  150. Seifert R. A., Coats S. A., Raines E. W., Ross R., Bowen-Pope D. F. Platelet-derived growth factor (PDGF) receptor alpha-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-beta can be mitogenic through PDGF A-chain-dependent and -independent pathways. J Biol Chem. 1994 May 13;269(19):13951–13955. [PubMed] [Google Scholar]
  151. Seifert R. A., Coats S. A., Raines E. W., Ross R., Bowen-Pope D. F. Platelet-derived growth factor (PDGF) receptor alpha-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-beta can be mitogenic through PDGF A-chain-dependent and -independent pathways. J Biol Chem. 1994 May 13;269(19):13951–13955. [PubMed] [Google Scholar]
  152. Sime P. J., Marr R. A., Gauldie D., Xing Z., Hewlett B. R., Graham F. L., Gauldie J. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol. 1998 Sep;153(3):825–832. doi: 10.1016/s0002-9440(10)65624-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Smith R. E., Strieter R. M., Phan S. H., Lukacs N., Kunkel S. L. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol. 1998 Oct;64(4):528–536. [PubMed] [Google Scholar]
  154. Snyder L. S., Hertz M. I., Peterson M. S., Harmon K. R., Marinelli W. A., Henke C. A., Greenheck J. R., Chen B., Bitterman P. B. Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest. 1991 Aug;88(2):663–673. doi: 10.1172/JCI115351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Sturani E., Brambilla R., Morello L., Cattaneo M. G., Zippel R., Alberghina L. Effect of the different dimeric forms of the platelet-derived growth factor on cellular responses in mouse Swiss 3T3 fibroblasts. FEBS Lett. 1989 Sep 11;255(1):191–195. doi: 10.1016/0014-5793(89)81089-0. [DOI] [PubMed] [Google Scholar]
  156. Sueoka N., Sueoka E., Miyazaki Y., Okabe S., Kurosumi M., Takayama S., Fujiki H. Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice. Cytokine. 1998 Feb;10(2):124–131. doi: 10.1006/cyto.1997.0267. [DOI] [PubMed] [Google Scholar]
  157. Tani K., Ogushi F., Takahashi H., Kawano T., Endo T., Sone S. Thrombin stimulates platelet-derived growth factor release by alveolar macrophages in rats--significance in bleomycin-induced pulmonary fibrosis. J Med Invest. 1997 Aug;44(1-2):59–65. [PubMed] [Google Scholar]
  158. Tsukamoto T., Matsui T., Nakata H., Ito M., Natazuka T., Fukase M., Fujita T. Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation. J Biol Chem. 1991 Jun 5;266(16):10143–10147. [PubMed] [Google Scholar]
  159. Turner-Warwick M., Haslam P. L. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1987 Jan;135(1):26–34. doi: 10.1164/arrd.1987.135.1.26. [DOI] [PubMed] [Google Scholar]
  160. Uhl E. W., Moldawer L. L., Busse W. W., Jack T. J., Castleman W. L. Increased tumor necrosis factor-alpha (TNF-alpha) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis. Am J Pathol. 1998 Feb;152(2):513–522. [PMC free article] [PubMed] [Google Scholar]
  161. Unemori E. N., Pickford L. B., Salles A. L., Piercy C. E., Grove B. H., Erikson M. E., Amento E. P. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest. 1996 Dec 15;98(12):2739–2745. doi: 10.1172/JCI119099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 1995 Oct;5(10):392–399. doi: 10.1016/s0962-8924(00)89088-1. [DOI] [PubMed] [Google Scholar]
  163. Vignaud J. M., Allam M., Martinet N., Pech M., Plenat F., Martinet Y. Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. Am J Respir Cell Mol Biol. 1991 Dec;5(6):531–538. doi: 10.1165/ajrcmb/5.6.531. [DOI] [PubMed] [Google Scholar]
  164. Vyalov S. L., Gabbiani G., Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol. 1993 Dec;143(6):1754–1765. [PMC free article] [PubMed] [Google Scholar]
  165. Wang Q., Wang Y., Hyde D. M., Gotwals P. J., Koteliansky V. E., Ryan S. T., Giri S. N. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax. 1999 Sep;54(9):805–812. doi: 10.1136/thx.54.9.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Watters L. C., Schwarz M. I., Cherniack R. M., Waldron J. A., Dunn T. L., Stanford R. E., King T. E. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis. 1987 Mar;135(3):696–704. doi: 10.1164/arrd.1987.135.3.696. [DOI] [PubMed] [Google Scholar]
  167. Xing Z., Tremblay G. M., Sime P. J., Gauldie J. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am J Pathol. 1997 Jan;150(1):59–66. [PMC free article] [PubMed] [Google Scholar]
  168. Yamamoto H., Ueno H., Ooshima A., Takeshita A. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture. J Biol Chem. 1996 Jul 5;271(27):16253–16259. doi: 10.1074/jbc.271.27.16253. [DOI] [PubMed] [Google Scholar]
  169. Yi E. S., Lee H., Yin S., Piguet P., Sarosi I., Kaufmann S., Tarpley J., Wang N. S., Ulich T. R. Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am J Pathol. 1996 Aug;149(2):539–548. [PMC free article] [PubMed] [Google Scholar]
  170. Yoshida M., Hayashi S. [Role of TGF-beta and PDGF on the pathogenesis of pulmonary fibrosis--analysis by in vivo gene transfer]. Nihon Rinsho. 1996 Feb;54(2):418–422. [PubMed] [Google Scholar]
  171. Yoshida M., Sakuma J., Hayashi S., Abe K., Saito I., Harada S., Sakatani M., Yamamoto S., Matsumoto N., Kaneda Y. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9570–9574. doi: 10.1073/pnas.92.21.9570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Zhang K., Gharaee-Kermani M., McGarry B., Remick D., Phan S. H. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol. 1997 Jan 15;158(2):954–959. [PubMed] [Google Scholar]
  173. Zhang Y., Lee T. C., Guillemin B., Yu M. C., Rom W. N. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol. 1993 May 1;150(9):4188–4196. [PubMed] [Google Scholar]
  174. Zhao Y., Gilmore B. J., Young S. L. Expression of transforming growth factor-beta receptors during hyperoxia-induced lung injury and repair. Am J Physiol. 1997 Aug;273(2 Pt 1):L355–L362. doi: 10.1152/ajplung.1997.273.2.L355. [DOI] [PubMed] [Google Scholar]
  175. Ziegenhagen M. W., Schrum S., Zissel G., Zipfel P. F., Schlaak M., Müller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med. 1998 Jun;46(5):223–231. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES